Exousia Bio, Inc.
LMMYCIK 0001939937 · Services-Educational Services · OTC
- LAMY (until 2026-01-15)
- L A M Y (until 2024-04-15)
Revenue (TTM)
$0
−67.4% YoY
Q3 Jun 2026
Net Income (TTM)
$91.07K
+299.2% YoY
Q3 Jun 2026
EPS Diluted (TTM)
$0.01
Q3 Jun 2026
Gross Margin
—
Q3 Jun 2026
Operating Margin
—
Q3 Jun 2026
Net Margin
—
Q3 Jun 2026
Free Cash Flow (TTM)
—
Q3 Jun 2026
Cash
$1.32K
Q3 Jun 2026
Total Debt
—
Q3 Jun 2026
Shares Outstanding
52.5M sh
Q3 Jun 2026